Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Fresenius Kabi Aktiengesellschaft
Pharmaceutical Preparation ManufacturingGermany
Last verified 1 month agofresenius-kabi.com
Fresenius Kabi Aktiengesellschaft, widely recognised as Fresenius Kabi, is a leading global healthcare company with its headquarters situated in Germany. Specialising in Pharmaceutical Preparation Manufacturing, the company operates across more than 100 countries, delivering essential products and services worldwide.
Established in 1999 as a subsidiary of Fresenius SE & Co. KGaA, Fresenius Kabi focuses on intravenously administered generic drugs, advanced infusion therapies, and comprehensive clinical nutrition products. They also provide crucial medical devices for the safe administration of these vital treatments, primarily for critically and chronically ill patients.
Fresenius Kabi is a global leader in its segments, known for its extensive portfolio and commitment to improving patient care. Its dedication to providing life-saving medicines and technologies solidifies its prominent market position in healthcare solutions.
60
DitchCarbon score
+18 vs industry average
Fresenius Kabi Aktiengesellschaft’s score of 60 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Fresenius Kabi Aktiengesellschaft?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Reported emissions
No reported emissions data is available for Fresenius Kabi Aktiengesellschaft yet.
Fresenius Kabi Aktiengesellschaft's reported carbon emissions
Fresenius Kabi Aktiengesellschaft, headquartered in Germany and operating in the Pharmaceutical Preparation Manufacturing industry, has its climate commitments and emissions data cascaded from its parent company, Fresenius SE & Co. KGaA.
While specific emissions data for Fresenius Kabi Aktiengesellschaft is not available, its climate-related disclosures, including CDP, are sourced from Fresenius SE & Co. KGaA. Further details regarding reduction targets or achievements would also be inherited from the parent organisation's overarching climate strategy.
Assessing Fresenius Kabi Aktiengesellschaft as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Fresenius Kabi Aktiengesellschaft and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Fresenius Kabi Aktiengesellschaft’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Fresenius Kabi Aktiengesellschaft yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
Inherited from Fresenius SE & Co. KGaASign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Fresenius Kabi Aktiengesellschaft1 month ago
60
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more